Novo Nordisk stock draws mixed views post guidance cut (NVO) - Seeking Alpha
Novo Nordisk (NVO) stock draws mixed views from Wall Street analysts after the obesity drugmaker cut its 2025 outlook for the second time this year. Read more here.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 125d372, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments